Results 191 to 200 of about 257,683 (336)
Abstract Idecabtagene vicleucel (ide‐cel, ABECMA) is an autologous, B‐cell maturation antigen‐directed, chimeric antigen receptor (CAR) T‐cell therapy, which has demonstrated significantly improved progression‐free survival (PFS) and overall response rate (ORR) in patients with triple‐class‐exposed relapsed/refractory multiple myeloma (TCE RRMM). Here,
Fan Wu+11 more
wiley +1 more source
Influence of Genetic Variation of GST, CYP, and ABC on the Safety and Efficacy of Cyclophosphamide-Based Therapy. [PDF]
Yao ZW+9 more
europepmc +1 more source
Effect of cyclophosphamide on the response of chickens to a virulent strain of Marek's disease virus [PDF]
Vali Kermani-Arab+4 more
openalex +1 more source
Utilization of Proteomic Measures for Early Detection of Drug Benefits and Adverse Effects
Abstract Recognition of benefits and adverse effects of therapies in earlier clinical trial phases could improve the safety, efficiency, and cost of clinical trials. Using four clinical trials representing a diverse set of diseases and drug classes (EXSCEL: exenatide/GLP‐1 RA, SUGAR‐DM‐HF: empagliflozin/SGLT2i, PRADA: epirubicin/anthracycline, and ...
Jessica Chadwick+17 more
wiley +1 more source
An Exploratory Retrospective Analysis of Racial Disparities in Fall-Related Injuries Among Black and White Breast Cancer Survivors Receiving Chemotherapy. [PDF]
Namoos A+4 more
europepmc +1 more source
Alveolar rhabdomyosarcoma of cervix: A case report. [PDF]
Zhang X, Xu J.
europepmc +1 more source
Effect of Cyclophosphamide on Suppressor Cell Activity in Mice Unresponsive to EAE [PDF]
Zeev Lando, Dvora Teitelbaum, Ruth Arnon
openalex +1 more source